Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Samsung Electronics(005930) – Other Management Matters (Voluntary Disclosure) / 2024-02-20

Posted on February 20, 2024July 29, 2026 By K-STOCK Editor No Comments on [Disclosure] Samsung Electronics(005930) – Other Management Matters (Voluntary Disclosure) / 2024-02-20

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Samsung Electronics’ Board of Directors has approved the operation of a KRW 12.27B CSR matching fund for 2024 and a KRW 2.469B donation to Chungnam Samsung Academy to improve educational environments.

📊 [Summary of Key Disclosure Details & Figures]

  • Disclosure Title: 2024 Corporate Social Responsibility (CSR) Matching Fund Operation Plan and Donation to Chungnam Samsung Academy
  • 2024 CSR Matching Fund Plan:
    • Matching Fund Amount: KRW 12.27B
    • Fund Nature: Matching fund where the company contributes an amount equal to employee donations from the previous year
    • Usage Plan: Social responsibility programs focused on youth education and vulnerable groups
  • Donation to Chungnam Samsung Academy:
    • Recipient: Chungnam Samsung Academy Educational Foundation
    • Donation Amount: KRW 2.469B
    • Scheduled Date of Donation: Early March 2024
    • Purpose: Enhancement of educational environments for employees’ children to attract outstanding talent and expansion of regional educational infrastructure
  • Board Resolution Date: February 20, 2024

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of Actual Donation Disbursement

Since this filing concerns the decision to operate a CSR fund and grant a donation, verifying whether the KRW 2.469B donation was actually disbursed in early March 2024 as scheduled is important to confirm the execution of the company’s CSR plans. Related disbursement details can be verified in upcoming periodic reports (Annual, Quarterly, or Half-Year Reports).

📢 Disclaimer & Source Notice

Source: This content was structured and regenerated based on official filings submitted to the Financial Supervisory Service’s DART system.

Investment Risk Warning: This content is provided strictly for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial liabilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] Samsung Electro-Mechanics (009150) – Board Resolution on Convening General Meeting of Shareholders / 2024-02-20
Next Post: [Disclosure] Samsung Electronics(005930) – Resolution on Convening of General Shareholders’ Meeting / 2024-02-20

Related Posts

[Disclosure] Samsung Electronics(005930) – (Correction) Long-term Business and Management Plan (Fair Disclosure) / 2025-01-31 Semiconductors
[Disclosure] Samsung Electronics (005930) – Decision on Overseas Stock Exchange Delisting / 2024-10-31 Semiconductors
[Disclosure] ALTEOGEN (196170) – Investor Relations (IR) Host / 2026-01-08 Disclosures
[Disclosure] SK Square (402340) – Clarification on Rumors or Reports / 2024-11-06 Semiconductors
[Disclosure] Jusung Engineering(036930) – Investor Relations (IR) Presentation / 2024-05-20 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Signs Supply Contract Worth Approx. KRW 388.2B with LIG Nex1 for IM3 Project Launcher Mass Production Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme